AKT1 and medullary thyroid gland carcinoma: In a recent study, the PI3K/AKT/mTOR pathway was shown to be activated in MTC, particularly in the metastatic lymph nodes, and this pathway was shown to sustain malignant features of different MTC cell models [47].